ABT vs GPCR · P/E 25, rev $44.33B vs $1.09B cap
Abbott Laboratories (ABT) versus Structure Therapeutics Inc. American Depositary Shares (GPCR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Structure Therapeutics Inc. American Depositary Shares (GPCR) is a biotechnology company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
GPCR does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GPCR currently screens at market cap $1.09B.
Not investment advice. Open the ABT and GPCR stock pages for the full models.
Not investment advice.